Activation of eukaryotic initiation factor-2α-kinases in okadaic acid-treated neurons

Neuroscience

Volumn 169, Issue 4, 2010, Pages 1831-1839

  Kim, S M ^a   Yoon, S Y ^a   Choi, J E ^a   Park, J S ^a   Choi, J M ^a   Nguyen, T ^a   Kim, D H ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Alzheimer's disease; Amino acids regulated eIF2 kinase; Double stranded RNA dependent protein kinase; Eukaryotic initiation factor 2 ; PKR like endoplasmic reticulum kinase

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 4; AMINO ACID REGULATED INITIATION FACTOR2ALPHA KINASE; INITIATION FACTOR 2ALPHA; OKADAIC ACID; PROTEIN KINASE; PROTEIN KINASE INHIBITOR; PROTEIN KINASE R; PROTEIN KINASE R LIKE ENDOPLASMIC RETICULUM KINASE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME LOCALIZATION; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; NERVE CELL; NERVE CELL CULTURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; WESTERN BLOTTING;

EID: 77955428915     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2010.06.016     Document Type: Article

References (52)

1. Arendt T., Holzer M., Fruth R., Bruckner M.K., Gartner U. Phosphorylation of tau, Abeta-formation, and apoptosis after in vivo inhibition of PP-1 and PP-2A. Neurobiol Aging 1998, 19:3-13.
2. Arriagada P.V., Growdon J.H., Hedley-Whyte E.T., Hyman B.T. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology 1992, 42:631-639.
3. Bullido M.J., Martinez-Garcia A., Tenorio R., Sastre I., Munoz D.G., Frank A., Valdivieso F. Double stranded RNA activated EIF2 alpha kinase (EIF2AK2; PKR) is associated with Alzheimer's disease. Neurobiol Aging 2008, 29:1160-1166.
4. Chafekar S.M., Hoozemans J.J., Zwart R., Baas F., Scheper W. Abeta 1-42 induces mild endoplasmic reticulum stress in an aggregation state-dependent manner. Antioxid Redox Signal 2007, 9:2245-2254.
5. Chafekar S.M., Zwart R., Veerhuis R., Vanderstichele H., Baas F., Scheper W. Increased Abeta1-42 production sensitizes neuroblastoma cells for ER stress toxicity. Curr Alzheimer Res 2008, 5:469-474.
6. Chang R.C., Suen K.C., Ma C.H., Elyaman W., Ng H.K., Hugon J. Involvement of double-stranded RNA-dependent protein kinase and phosphorylation of eukaryotic initiation factor-2alpha in neuronal degeneration. J Neurochem 2002, 83:1215-1225.
7. Chang R.C., Wong A.K., Ng H.K., Hugon J. Phosphorylation of eukaryotic initiation factor-2alpha (eIF2alpha) is associated with neuronal degeneration in Alzheimer's disease. Neuroreport 2002, 13:2429-2432.
8. Connor J.H., Weiser D.C., Li S., Hallenbeck J.M., Shenolikar S. Growth arrest and DNA damage-inducible protein GADD34 assembles a novel signaling complex containing protein phosphatase 1 and inhibitor 1. Mol Cell Biol 2001, 21:6841-6850.
9. Costa-Mattioli M., Gobert D., Harding H., Herdy B., Azzi M., Bruno M., Bidinosti M., Ben Mamou C., Marcinkiewicz E., Yoshida M., Imataka H., Cuello A.C., Seidah N., Sossin W., Lacaille J.C., Ron D., Nader K., Sonenberg N. Translational control of hippocampal synaptic plasticity and memory by the eIF2alpha kinase GCN2. Nature 2005, 436:1166-1173.
10. Garcia-Barrio M., Dong J., Cherkasova V.A., Zhang X., Zhang F., Ufano S., Lai R., Qin J., Hinnebusch A.G. Serine 577 is phosphorylated and negatively affects the tRNA binding and eIF2alpha kinase activities of GCN2. J Biol Chem 2002, 277:30675-30683.
11. Gebauer F., Hentze M.W. Molecular mechanisms of translational control. Nat Rev Mol Cell Biol 2004, 5:827-835.
12. Gil J., Esteban M. Induction of apoptosis by the dsRNA-dependent protein kinase (PKR): mechanism of action. Apoptosis 2000, 5:107-114.
13. Gomez-Isla T., Hollister R., West H., Mui S., Growdon J.H., Petersen R.C., Parisi J.E., Hyman B.T. Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease. Ann Neurol 1997, 41:17-24.
14. Gong C.X., Lidsky T., Wegiel J., Zuck L., Grundke-Iqbal I., Iqbal K. Phosphorylation of microtubule-associated protein tau is regulated by protein phosphatase 2A in mammalian brain. Implications for neurofibrillary degeneration in Alzheimer's disease. J Biol Chem 2000, 275:5535-5544.
15. Gong C.X., Shaikh S., Wang J.Z., Zaidi T., Grundke-Iqbal I., Iqbal K. Phosphatase activity toward abnormally phosphorylated tau: decrease in Alzheimer disease brain. J Neurochem 1995, 65:732-738.
16. Grundke-Iqbal I., Iqbal K., Tung Y.C., Quinlan M., Wisniewski H.M., Binder L.I. Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci U S A 1986, 83:4913-4917.
17. Harding H.P., Zhang Y., Ron D. Protein translation and folding are coupled by an endoplasmic-reticulum-resident kinase. Nature 1999, 397:271-274.
18. Hoozemans J.J., van Haastert E.S., Nijholt D.A., Rozemuller A.J., Eikelenboom P., Scheper W. The unfolded protein response is activated in pretangle neurons in Alzheimer's disease hippocampus. Am J Pathol 2009, 174:1241-1251.
19. Hoozemans J.J., Veerhuis R., Van Haastert E.S., Rozemuller J.M., Baas F., Eikelenboom P., Scheper W. The unfolded protein response is activated in Alzheimer's disease. Acta Neuropathol 2005, 110:165-172.
20. Hugon J., Paquet C., Chang R.C. Could PKR inhibition modulate human neurodegeneration?. Expert Rev Neurother 2009, 9:1455-1457.
21. Jousse C., Oyadomari S., Novoa I., Lu P., Zhang Y., Harding H.P., Ron D. Inhibition of a constitutive translation initiation factor 2alpha phosphatase, CReP, promotes survival of stressed cells. J Cell Biol 2003, 163:767-775.
22. Kilberg M.S., Shan J., Su N. ATF4-dependent transcription mediates signaling of amino acid limitation. Trends Endocrinol Metab 2009, 20:436-443.
23. Kim D., Su J., Cotman C.W. Sequence of neurodegeneration and accumulation of phosphorylated tau in cultured neurons after okadaic acid treatment. Brain Res 1999, 839:253-262.
24. Kim R., Emi M., Tanabe K., Murakami S. Role of the unfolded protein response in cell death. Apoptosis 2006, 11:5-13.
25. Lai C.S., Preisler J., Baum L., Lee D.H., Ng H.K., Hugon J., So K.F., Chang R.C. Low molecular weight Abeta induces collapse of endoplasmic reticulum. Mol Cell Neurosci 2009, 41:32-43.
26. Lemaire P.A., Anderson E., Lary J., Cole J.L. Mechanism of PKR activation by dsRNA. J Mol Biol 2008, 381:351-360.
27. Mackay E.A., Ehrhard A., Moniatte M., Guenet C., Tardif C., Tarnus C., Sorokine O., Heintzelmann B., Nay C., Remy J.M., Higaki J., Van Dorsselaer A., Wagner J., Danzin C., Mamont P. A possible role for cathepsins D, E, and B in the processing of beta-amyloid precursor protein in Alzheimer's disease. Eur J Biochem 1997, 244:414-425.
28. Mitsuda T., Hayakawa Y., Itoh M., Ohta K., Nakagawa T. ATF4 regulates gamma-secretase activity during amino acid imbalance. Biochem Biophys Res Commun 2007, 352:722-727.
29. Novoa I., Zeng H., Harding H.P., Ron D. Feedback inhibition of the unfolded protein response by GADD34-mediated dephosphorylation of eIF2alpha. J Cell Biol 2001, 153:1011-1022.
30. O'Connor T., Sadleir K.R., Maus E., Velliquette R.A., Zhao J., Cole S.L., Eimer W.A., Hitt B., Bembinster L.A., Lammich S., Lichtenthaler S.F., Hebert S.S., De S.B., Haass C., Bennett D.A., Vassar R. Phosphorylation of the translation initiation factor eIF2alpha increases BACE1 levels and promotes amyloidogenesis. Neuron 2008, 60:988-1009.
31. Onuki R., Bando Y., Suyama E., Katayama T., Kawasaki H., Baba T., Tohyama M., Taira K. An RNA-dependent protein kinase is involved in tunicamycin-induced apoptosis and Alzheimer's disease. EMBO J 2004, 23:959-968.
32. Paccalin M., Pain-Barc S., Pluchon C., Paul C., Besson M.N., Carret-Rebillat A.S., Rioux-Bilan A., Gil R., Hugon J. Activated mTOR and PKR kinases in lymphocytes correlate with memory and cognitive decline in Alzheimer's disease. Dement Geriatr Cogn Disord 2006, 22:320-326.
33. Page G., Rioux Bilan A., Ingrand S., Lafay-Chebassier C., Pain S., Perault Pochat M.C., Bouras C., Bayer T., Hugon J. Activated double-stranded RNA-dependent protein kinase and neuronal death in models of Alzheimer's disease. Neuroscience 2006, 139:1343-1354.
34. Peel A.L., Bredesen D.E. Activation of the cell stress kinase PKR in Alzheimer's disease and human amyloid precursor protein transgenic mice. Neurobiol Dis 2003, 14:52-62.
35. Schapansky J., Olson K., Van Der Ploeg R., Glazner G. NF-kappaB activated by ER calcium release inhibits Abeta-mediated expression of CHOP protein: enhancement by AD-linked mutant presenilin 1. Exp Neurol 2007, 208:169-176.
36. Shi Y., Vattem K.M., Sood R., An J., Liang J., Stramm L., Wek R.C. Identification and characterization of pancreatic eukaryotic initiation factor 2 alpha-subunit kinase, PEK, involved in translational control. Mol Cell Biol 1998, 18:7499-7509.
37. Shimazawa M., Hara H. Inhibitor of double stranded RNA-dependent protein kinase protects against cell damage induced by ER stress. Neurosci Lett 2006, 409:192-195.
38. Sontag E., Hladik C., Montgomery L., Luangpirom A., Mudrak I., Ogris E., White C.L. Downregulation of protein phosphatase 2A carboxyl methylation and methyltransferase may contribute to Alzheimer disease pathogenesis. J Neuropathol Exp Neurol 2004, 63:1080-1091.
39. Sontag E., Luangpirom A., Hladik C., Mudrak I., Ogris E., Speciale S., White C.L. Altered expression levels of the protein phosphatase 2A ABalphaC enzyme are associated with Alzheimer disease pathology. J Neuropathol Exp Neurol 2004, 63:287-301.
40. Sun L., Liu S.Y., Zhou X.W., Wang X.C., Liu R., Wang Q., Wang J.Z. Inhibition of protein phosphatase 2A- and protein phosphatase 1-induced tau hyperphosphorylation and impairment of spatial memory retention in rats. Neuroscience 2003, 118:1175-1182.
41. Takahashi R.H., Milner T.A., Li F., Nam E.E., Edgar M.A., Yamaguchi H., Beal M.F., Xu H., Greengard P., Gouras G.K. Intraneuronal Alzheimer abeta42 accumulates in multivesicular bodies and is associated with synaptic pathology. Am J Pathol 2002, 161:1869-1879.
42. Tanimukai H., Grundke-Iqbal I., Iqbal K. Up-regulation of inhibitors of protein phosphatase-2A in Alzheimer's disease. Am J Pathol 2005, 166:1761-1771.
43. Unterberger U., Hoftberger R., Gelpi E., Flicker H., Budka H., Voigtlander T. Endoplasmic reticulum stress features are prominent in Alzheimer disease but not in prion diseases in vivo. J Neuropathol Exp Neurol 2006, 65:348-357.
44. Vickers J.C., Dickson T.C., Adlard P.A., Saunders H.L., King C.E., McCormack G. The cause of neuronal degeneration in Alzheimer's disease. Prog Neurobiol 2000, 60:139-165.
45. Vogelsberg-Ragaglia V., Schuck T., Trojanowski J.Q., Lee V.M. PP2A mRNA expression is quantitatively decreased in Alzheimer's disease hippocampus. Exp Neurol 2001, 168:402-412.
46. Wang J., Tung Y.C., Wang Y., Li X.T., Iqbal K., Grundke-Iqbal I. Hyperphosphorylation and accumulation of neurofilament proteins in Alzheimer disease brain and in okadaic acid-treated SY5Y cells. FEBS Lett 2001, 507:81-87.
47. Weiser D.C., Shenolikar S. Use of protein phosphatase inhibitors. Curr Protoc Mol Biol 2003, Chapter 18:Unit 18.10.
48. Wek R.C., Jiang H.Y., Anthony T.G. Coping with stress: eIF2 kinases and translational control. Biochem Soc Trans 2006, 34:7-11.
49. Wek S.A., Zhu S., Wek R.C. The histidyl-tRNA synthetase-related sequence in the eIF-2 alpha protein kinase GCN2 interacts with tRNA and is required for activation in response to starvation for different amino acids. Mol Cell Biol 1995, 15:4497-4506.
50. Williams B.R. PKR; a sentinel kinase for cellular stress. Oncogene 1999, 18:6112-6120.
51. Yoon S.Y., Choi J.E., Huh J.W., Hwang O., Lee H.S., Hong H.N., Kim D. Monastrol, a selective inhibitor of the mitotic kinesin Eg5, induces a distinctive growth profile of dendrites and axons in primary cortical neuron cultures. Cell Motil Cytoskeleton 2005, 60:181-190.
52. Yoon S.Y., Choi J.E., Yoon J.H., Huh J.W., Kim D.H. BACE inhibitor reduces APP-beta-C-terminal fragment accumulation in axonal swellings of okadaic acid-induced neurodegeneration. Neurobiol Dis 2006, 22:435-444.